NCT06549959View on ClinicalTrials.gov

A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Healthy
Interventions
DRUG

Telitacicept Pre-filled Injection 80mg

The patient received one treatment of Telitacicept 80mg in the test group

DRUG

Telitacicept Freeze-dried powder Injection 80mg

The patient received one treatment of Telitacicept 80mg in the test group

Trial Locations (3)

300191

RECRUITING

Tianjin People's Hospital, Tianjin

550004

RECRUITING

The Affiliated Hospital of Guizhou Medical University, Guiyang

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

RemeGen Co., Ltd.

INDUSTRY